Increased expression of Cardiotrophin-1 in cardiomyopathy patients
, , , , , and
Jul 27, 2021
About this article
Article Category: Original Article
Published Online: Jul 27, 2021
Page range: 21 - 26
DOI: https://doi.org/10.2478/bjmg-2021-0008
Keywords
© 2021 Sharif S, Saleem A, Naz S, Rashid F, Iqtedar M, Kaleem A, Latif A, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Figure 1

Figure 2

Demographic parameters of the cardiomyopathy and control groups_
Parameters | CM Group ( |
Control Group ( |
---|---|---|
Age (years) | 40.10±6.03 | 35.00±3.71 |
BMI (kg/m2) | 25.11±0.39 | 24.22±0.66 |
SBP (mmHg) | 124.0±0.7 | 103.0±0.9 |
DBP (mmHg) | 83.0±0.8 | 79.0±1.5 |
5.29±0.34 | 1.00 |
Prevalence of physical activity, etiological attributes and symptomatology in the cardiomyopathy group_
Variables | CM Group ( |
---|---|
Physical activity (%) | |
vigorous | 5.0 |
moderate | 20.0 |
sedentary | 75.0 |
Etiological attributes (%) | |
idiopathic | 65.0 |
nutritional | 15.0 |
multifactorial | 15.0 |
Symptomatology (%) | |
breathless | 85.0 |
palpitations | 75.0 |
chest pain | 45.0 |
Correlation between the cardiotrophin-1 gene and demographic parameters in cardiomyopathy group_
Parameters | ||
---|---|---|
Age (years) | 0.54a | <0.05 |
BMI (kg/m2) | 0.46b | <0.01 |
SBP (mmHg) | –0.079 | >0.05 |
DBP (mmHg) | 0.069 | >0.05 |